Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 19 - Number 11
Biography Open Access
Review Article
The Role of Shcbp1 in Signaling and Disease
, 19(11): 854 - 862Geng-Yuan Zhang, Zhi-Jian Ma, Long Wang, Ruo-Fei Sun, Xiang-Yan Jiang, Xu-Juan Yang, Bo Long, Hui-Li Ye, Shu-Ze Zhang, Ze-Yuan Yu, Wen-Gui Shi and Zuo-Yi Jiao*
DOI: 10.2174/1568009619666190620114928
The Role of Shcbp1 in Signaling and Disease
Review Article
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
, 19(11): 863 - 876Xinjie Lu*
DOI: 10.2174/1568009619666190802135714
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
Review Article
Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics
, 19(11): 877 - 884Ishita Tandon, Asawari Waghmode and Nilesh Kumar Sharma*
DOI: 10.2174/1568009619666190808155432
Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics
Research Article
Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
, 19(11): 885 - 895Jun Chen, Demin Jiao, Yu Li, Chunyan Jiang, Xiali Tang, Jia Song and Qingyong Chen*
DOI: 10.2174/1568009619666190619154240
Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
Research Article
Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients
, 19(11): 896 - 905Fatma El-Gebaly , Sabry Abou-saif , Mahmoud Elkadeem, Amal Helmy, Sherief Abd-Elsalam *, Mohamed Yousef, Reham Abdelkader Elkhouly, Ibrahim Fathi Amer and Taher El-Demerdash
DOI: 10.2174/1568009619666190718141647
Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients
Research Article
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
, 19(11): 906 - 918Maria Yousuf*
DOI: 10.2174/1568009619666190320102238
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
Research Article
Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
, 19(11): 919 - 929Mohammad Asad, Saima Wajid, Deepshikha Pande Katare, Ruchi Jakhmola Mani and Swatantra Kumar Jain*
DOI: 10.2174/1871525717666190717162646
Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
Acknowledgement Open Access
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net